SAN JOSE, Calif.--(BUSINESS WIRE)--Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the Lenti-X™ Transduction Sponge, a first-to-market dissolvable ...
Takara Bio USA, Inc. ("Takara Bio USA"), a wholly owned subsidiary of Takara Bio Inc. ("Takara Bio"), today announced a series of updates to its spatial biology product portfolio, extending its ...
SAN JOSE, Calif.--(BUSINESS WIRE)--Takara Bio USA, Inc., a pioneering life science reagent and instrument company and wholly owned subsidiary of Takara Bio Inc., is partnering with BioExcel ...
This strategic acquisition combines two innovative spatial biology platforms with Takara Bio’s industry-leading portfolio of single-cell genomics tools. TBUSH is a wholly owned subsidiary of Takara ...
New capabilities mark continued momentum as company advances discovery research applications and accelerates the global growth of its spatial biology business Takara Bio USA, Inc. (“Takara Bio USA”), ...
Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the SmartChip ND™ Real-Time PCR System, an automated, research-use-only (RUO), high-throughput qPCR ...
Takara Bio USA is a wholly-owned subsidiary of Takara Bio who manufactures and distributes research-use-only (RUO) kits, reagents and instruments for the life sciences, including next-generation ...
Takara Bio Inc. has announced the development of a novel adeno-associated virus (AAV) vector, Sonuaav, which exhibits high gene transfer efficiency into inner ear tissues, with a collaborator at ...
For over 50 years, Takara Bio has been committed to helping scientists break new ground with our innovative technologies. Our extensive portfolio of reagents, instruments, and services support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results